News

Onward Partners with IP Infusion for Cutting-Edge Networking Solutions

Onward Partners with IP Infusion for Cutting-Edge Networking Solutions

Onward Partners with IP Infusion for Networking Enhancement

Onward has made a significant decision by selecting IP Infusion as its provider for networking solutions. This partnership is aimed at enhancing network performance to keep up with the increasing demands from both business and residential customers.

About Onward and its Growing Needs

Onward is a well-known provider of full-fiber network services. As the company expands rapidly, there’s a pressing need for better networking equipment to fulfill the rising service demands from both residential and business sectors. In the past, Onward faced challenges with outdated networking technology that led to stability problems and insufficient vendor support.

Transitioning to a Modern Networking Framework

To modernize its approach, Onward has adopted the innovative OcNOS-SP-MPLS networking software from IP Infusion. This strategic move is designed to enhance Onward’s network capabilities, enabling the company to support services at 100 Gbps for core and aggregation purposes without a hitch.

Advanced Hardware Integration with UfiSpace

This deployment also includes advanced hardware from UfiSpace, such as the S9600-32X, known for its strong performance, and the fanless, temperature-hardened S9502-12SM, which ensures stable core connections. The collaboration with IP Infusion promises a thorough solution that includes centralized maintenance and support for Onward.

Seamless Integration and Scalability

A major advantage of IP Infusion’s OcNOS is its ability to integrate smoothly with existing network infrastructures. This seamless integration allows Onward to upgrade its systems with minimal disruption. The flexible infrastructure makes it possible to introduce new, innovative features, significantly enhancing network operations.

Leadership Insights on the Upgrade

Nick Keeler, Onward’s CEO, highlighted the significance of this upgrade, stating, “Onward needed network scalability and resilience. Over time, our previous platform became problematic. The OcNOS product works well with hardware from various vendors, providing a scalable solution that supports our growth.”

IP Infusion's Commitment to Innovation

Atsushi Ogata, the President and CEO of IP Infusion, expressed the company’s dedication to supporting growth for businesses like Onward. He said, "IP Infusion is committed to offering open networking software solutions. We are consistently excited to assist dynamic companies that adapt quickly to market shifts. Our flexible solutions have proven their worth time and again."

Understanding IP Infusion's Contributions

IP Infusion is well-regarded for its open network software and solutions tailored for carriers, service providers, and data centers. Their flagship platform, OcNOS, empowers network operators to simplify their processes through network disaggregation, which ultimately lowers the Total Cost of Ownership (TCO). This capability enables Network Original Equipment Manufacturers (OEMs) to innovate more quickly and deliver comprehensive services with confidence.

The Future of Networking with IP Infusion

Based in Santa Clara, IP Infusion is a subsidiary of ACCESS CO., LTD. The company continues to solidify its leadership in Network Operating Systems, forming strategic partnerships that empower service providers like Onward for a successful future. With their combined technologies, both companies are poised to make significant progress in network reliability and service delivery capabilities.

Frequently Asked Questions

What motivated Onward to partner with IP Infusion?

Onward sought scalable and resilient networking solutions to better serve its growing customer base and improve service quality.

What technologies are being implemented in this partnership?

Onward is using IP Infusion’s OcNOS-SP-MPLS networking software, along with hardware solutions from UfiSpace to enhance network performance.

How does the upgrade impact Onward's existing network?

The upgrade integrates smoothly with Onward's current network, allowing the introduction of new features with minimal disruption.

What is the vision of IP Infusion in this collaboration?

IP Infusion aims to assist companies like Onward by providing innovative and flexible networking solutions that respond to market changes.

How does this upgrade enhance Onward’s service delivery?

This upgrade significantly increases scalability and resilience, thereby improving overall service delivery for Onward’s business and residential customers.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 8

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 4

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 7

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 6

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 3

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 3

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 6

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 3

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Important Shareholder Investigations in Various Companies

Updated Category News Views 261

Overview of Current Shareholder Investigations Brodsky & Smith, a well-known litigation law firm, is actively reminding shareholders about various ongoing investigations involving Sealed Air Corporation, Movano Inc., Gulf Island Inc., and Denny's Corporation. If you are a shareholder interested in obtaining more information regarding these investigations, you can reach...

Continue Reading
Nykredit Announces Voluntary Tender Offer for Spar Nord Bank

Updated Category News Views 147

Nykredit Announces a Voluntary Public Tender Offer for Spar Nord Bank Nykredit Realkredit A/S, a prominent player in the Danish financial landscape, has publicly unveiled its plans for a voluntary tender offer directed at Spar Nord Bank A/S. This anticipated offer, which signals Nykredit's strategic expansion ambitions, seeks to acquire all available shares in Spar Nord...

Continue Reading
Big 5 Sporting Goods Embarks on New Growth Journey After Merger

Updated Category News Views 292

Big 5 Sporting Goods Corporation Announces Merger Completion Big 5 Sporting Goods Corporation (Nasdaq: BGFV), a well-established name in the sporting goods industry, has successfully completed its merger with a partnership composed of Worldwide Golf and Capitol Hill Group. This new chapter for Big 5 is expected to propel the company towards greater heights. Merger Details...

Continue Reading
UCB's BIMZELX® Data: A Game Changer for Arthritis Care

Updated Category News Views 132

UCB's Innovative Efforts in Arthritis Treatment UCB is making significant strides in the field of rheumatology, particularly with the release of new data regarding BIMZELX® (bimekizumab-bkzx) presented at the ACR Convergence 2024. This marks the first time the company has shared data specifically relating to psoriatic arthritis (PsA), non-radiographic axial...

Continue Reading
Mega Matrix Launches Captivating Urban Romance on FlexTV

Updated Category News Views 614

Engaging Romance Premieres on FlexTV Mega Matrix Inc. (NYSE American: MPU) has unveiled a captivating romantic miniseries titled A flash Marriage With The Billionaire Tycoon, streaming on its renowned short series platform, FlexTV. This adventurous drama dives into themes of love, responsibility, and the quest for personal redemption, showcasing the complicated lives of...

Continue Reading